CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 8-Br-cAMP
Accession: CHEBI:64211
browse the term
Definition: A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic AMP bearing an additional bromo substituent at position 8 on the adenine ring. An activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.
Synonyms: exact_synonym: 8-bromoadenosine 3',5'-(hydrogen phosphate)
related_synonym: (4aR,6R,7R,7aS)-6-(6-amino-8-bromo-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide; 8-Bromo-cAMP; 8-bromo cyclic adenosine monophosphate; 8-bromo-cyclic 3',5'-AMP; 8-bromo-cyclic AMP; 8-bromoadenosine 3',5'-cyclic monophosphate; 8-bromoadenosine 3',5'-monophosphate; 8-bromoadenosine cyclic 3',5'-phosphate; BCAMP; Formula=C10H11BrN5O6P; InChI=1S/C10H11BrN5O6P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14)/t3-,5-,6-,9-/m1/s1; InChIKey=DVKQVRZMKBDMDH-UUOKFMHZSA-N; SMILES=Nc1ncnc2n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c(Br)nc12
alt_id: CHEBI:145729; CHEBI:84608
xref: CAS:23583-48-4
xref_mesh: MESH:D015124
xref: PMID:10543424; PMID:10708595; PMID:11906532; PMID:12216111; PMID:1320750; PMID:1367038; PMID:15121638; PMID:15169861; PMID:15225757; PMID:15717604; PMID:16134057; PMID:16214133; PMID:16425431; PMID:17140607; PMID:18239846; PMID:1849229; PMID:19121393; PMID:1982459; PMID:19833172; PMID:21120637; PMID:21284604; PMID:2240104; PMID:2413029; PMID:24493289; PMID:24518258; PMID:24605759; PMID:2478258; PMID:2560108; PMID:2581952; PMID:2744214; PMID:29887570; PMID:29997437; PMID:3032362; PMID:30374127; PMID:3094467; PMID:6128338; PMID:6196214; PMID:6327153; PMID:6367831; PMID:7996791; PMID:8095554; PMID:8107042; PMID:8394699; PMID:8699249; PMID:8730238; PMID:8841091; PMID:9042334; PMID:9327456; PMID:9713380; Reaxys:591930; Wikipedia:8-Bromoadenosine_3'\,5'-cyclic_monophosphate
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ABCA1 protein
CTD
PMID:17478430
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of ABCB11 mRNA]
CTD
PMID:27743861
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc1
ATP binding cassette subfamily C member 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCC1 mRNA
CTD
PMID:22079614
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of ABCC2 mRNA]
CTD
PMID:27743861
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcd2
ATP binding cassette subfamily D member 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCD2 mRNA
CTD
PMID:22079614
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
G
Abcg1
ATP binding cassette subfamily G member 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCG1 mRNA
CTD
PMID:22079614
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [anandamide results in decreased expression of ABCG2 mRNA]
CTD
PMID:30610963
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ablim1
actin-binding LIM protein 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABLIM1 mRNA
CTD
PMID:22079614
NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969
G
Ablim2
actin binding LIM protein family, member 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ABLIM2 mRNA
CTD
PMID:22079614
NCBI chr14:74,865,409...74,990,334
Ensembl chr14:74,866,281...74,990,334
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ACAT2 mRNA
CTD
PMID:22079614
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Ace2
angiotensin converting enzyme 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ACE2 mRNA
CTD
PMID:22079614
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acp3
acid phosphatase 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ACP3 mRNA
CTD
PMID:22079614
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
G
Adamts6
ADAM metallopeptidase with thrombospondin type 1 motif, 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ADAMTS6 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
G
Adamts8
ADAM metallopeptidase with thrombospondin type 1 motif, 8
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADAMTS8 mRNA
CTD
PMID:22079614
NCBI chr 8:29,349,078...29,368,413
Ensembl chr 8:29,349,114...29,368,404
G
Adcy7
adenylate cyclase 7
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADCY7 mRNA
CTD
PMID:22079614
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Adgrd1
adhesion G protein-coupled receptor D1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ADGRD1 mRNA
CTD
PMID:22079614
NCBI chr12:27,488,908...27,603,714
Ensembl chr12:27,488,908...27,603,696
G
Adgrf5
adhesion G protein-coupled receptor F5
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADGRF5 mRNA
CTD
PMID:16997883
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
G
Adgrg1
adhesion G protein-coupled receptor G1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ADGRG1 mRNA
CTD
PMID:22079614
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
G
Adgrg2
adhesion G protein-coupled receptor G2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADGRG2 mRNA
CTD
PMID:22079614
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
G
Adra2a
adrenoceptor alpha 2A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADRA2A mRNA
CTD
PMID:22079614
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA
CTD
PMID:16997883
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Agt
angiotensinogen
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AGT mRNA
CTD
PMID:22079614
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AGTR1 mRNA
CTD
PMID:22079614
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AHR mRNA
CTD
PMID:22079614
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AIFM1 mRNA
CTD
PMID:22079614
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akap7
A-kinase anchoring protein 7
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA
CTD
PMID:16997883
NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797
G
Akap9
A-kinase anchoring protein 9
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AKAP9 mRNA
CTD
PMID:22079614
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akt1
AKT serine/threonine kinase 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AKT1 mRNA
CTD
PMID:22079614
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ALB mRNA
CTD
PMID:22079614
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ALDH1A1 mRNA
CTD
PMID:22079614
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Angpt1
angiopoietin 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ANGPT1 mRNA
CTD
PMID:16997883
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Angptl1
angiopoietin-like 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ANGPTL1 mRNA
CTD
PMID:22079614
NCBI chr13:68,963,186...68,981,649
Ensembl chr13:68,962,991...68,992,570
G
Ankh
ANKH inorganic pyrophosphate transport regulator
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ANKH mRNA
CTD
PMID:20147733
NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
G
Anxa8
annexin A8
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of ANXA8 mRNA
CTD
PMID:16997883
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Aopep
aminopeptidase O
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AOPEP mRNA
CTD
PMID:22079614
NCBI chr17:1,811,281...2,127,316
Ensembl chr17:1,811,980...2,127,331
G
Apaf1
apoptotic peptidase activating factor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of APAF1 mRNA
CTD
PMID:22079614
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apbb1ip
amyloid beta precursor protein binding family B member 1 interacting protein
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of APBB1IP mRNA
CTD
PMID:22079614
NCBI chr17:84,941,404...85,033,020
Ensembl chr17:84,982,243...85,033,010
G
Apc
APC regulator of WNT signaling pathway
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of APC mRNA
CTD
PMID:22079614
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Apcdd1
APC down-regulated 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of APCDD1 mRNA
CTD
PMID:22079614
NCBI chr18:56,385,398...56,416,065
Ensembl chr18:56,385,264...56,416,070
G
Ar
androgen receptor
decreases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AR mRNA [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of AR mRNA; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of AR mRNA]
CTD
PMID:18467523 PMID:22079614
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AREG mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arhgef2
Rho/Rac guanine nucleotide exchange factor 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARHGEF2 mRNA
CTD
PMID:22079614
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
G
Arhgef4
Rho guanine nucleotide exchange factor 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARHGEF4 mRNA
CTD
PMID:22079614
NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075
G
Arid5b
AT-rich interaction domain 5B
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARID5B mRNA
CTD
PMID:22079614
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
G
Armcx3
armadillo repeat containing, X-linked 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARMCX3 mRNA
CTD
PMID:22079614
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
G
Armcx4
armadillo repeat containing, X-linked 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARMCX4 mRNA
CTD
PMID:22079614
NCBI chr X:97,860,526...97,870,912
Ensembl chr X:97,860,629...97,870,912
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ASNS mRNA
CTD
PMID:22079614
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atp4a
ATPase H+/K+ transporting subunit alpha
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ATP4A mRNA
CTD
PMID:22079614
NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844
G
Avpi1
arginine vasopressin-induced 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AVPI1 mRNA
CTD
PMID:22079614
NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154
G
B4galnt3
beta-1,4-N-acetyl-galactosaminyl transferase 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of B4GALNT3 mRNA
CTD
PMID:22079614
NCBI chr 4:153,409,019...153,509,019
Ensembl chr 4:153,409,004...153,509,321
G
Bank1
B-cell scaffold protein with ankyrin repeats 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BANK1 mRNA
CTD
PMID:22079614
NCBI chr 2:224,530,475...224,800,420
Ensembl chr 2:224,530,475...224,800,405
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BAX [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BAX protein
CTD
PMID:11802967 PMID:16709600
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcat1
branched chain amino acid transaminase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BCAT1 mRNA
CTD
PMID:22079614
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BCL2
CTD
PMID:11802967
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l11
Bcl2-like 11
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein
CTD
PMID:16709600
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bdkrb1
bradykinin receptor B1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BDKRB1 mRNA
CTD
PMID:20147733
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
G
Bdkrb2
bradykinin receptor B2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BDKRB2 mRNA
CTD
PMID:20147733
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bmp4
bone morphogenetic protein 4
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BMP4 mRNA
CTD
PMID:22079614
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bmp6
bone morphogenetic protein 6
decreases expression increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BMP6 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BMP6 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Brinp1
BMP/retinoic acid inducible neural specific 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BRINP1 mRNA
CTD
PMID:20147733
NCBI chr 5:82,348,501...82,550,506
Ensembl chr 5:82,348,930...82,493,150
G
Btbd9
BTB domain containing 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BTBD9 mRNA
CTD
PMID:22079614
NCBI chr20:8,286,337...8,645,567
Ensembl chr20:8,288,711...8,643,960
G
Cables1
Cdk5 and Abl enzyme substrate 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CABLES1 mRNA
CTD
PMID:22079614
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
G
Cabp7
calcium binding protein 7
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CABP7 mRNA
CTD
PMID:22079614
NCBI chr14:79,598,822...79,609,172
Ensembl chr14:79,598,827...79,609,240
G
Cadm1
cell adhesion molecule 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CADM1 mRNA
CTD
PMID:22079614
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
G
Cadm2
cell adhesion molecule 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CADM2 mRNA
CTD
PMID:22079614
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
G
Caln1
calneuron 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CALN1 mRNA
CTD
PMID:22079614
NCBI chr12:25,811,743...26,303,670
Ensembl chr12:25,819,628...26,303,344
G
Calr
calreticulin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CALR mRNA
CTD
PMID:22079614
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAMK2N1 mRNA
CTD
PMID:22079614
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Capn15
calpain 15
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CAPN15 mRNA
CTD
PMID:22079614
NCBI chr10:14,972,807...14,999,411
Ensembl chr10:14,972,800...14,999,508
G
Capn2
calpain 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAPN2 mRNA
CTD
PMID:22079614
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Capn6
calpain 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAPN6 mRNA
CTD
PMID:22079614
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
G
Card14
caspase recruitment domain family, member 14
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CARD14 mRNA
CTD
PMID:22079614
NCBI chr10:104,572,059...104,601,606
Ensembl chr10:104,566,424...104,601,905
G
Cars1
cysteinyl-tRNA synthetase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CARS1 mRNA
CTD
PMID:22079614
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
G
Casp3
caspase 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CASP3 mRNA
CTD
PMID:22079614
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CASP9 mRNA
CTD
PMID:22079614
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CAT mRNA
CTD
PMID:16709600
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cbr4
carbonyl reductase 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CBR4 mRNA
CTD
PMID:22079614
NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712
G
Ccdc170
coiled-coil domain containing 170
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCDC170 mRNA
CTD
PMID:22079614
NCBI chr 1:40,945,607...41,050,010
Ensembl chr 1:40,945,961...41,085,040
G
Ccdc3
coiled-coil domain containing 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCDC3 mRNA
CTD
PMID:22079614
NCBI chr17:73,031,891...73,135,173
Ensembl chr17:73,035,045...73,135,337
G
Ccdc80
coiled-coil domain containing 80
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCDC80 mRNA
CTD
PMID:22079614
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]]; [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCL2 protein
CTD
PMID:11230753 PMID:16997883 PMID:20940016
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]
CTD
PMID:10495789
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn3
cellular communication network factor 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCN3 mRNA
CTD
PMID:22079614
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
G
Ccn6
cellular communication network factor 6
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCN6 mRNA
CTD
PMID:22079614
NCBI chr20:42,569,309...42,585,126
Ensembl chr20:42,569,309...42,585,126
G
Ccna1
cyclin A1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCNA1 mRNA
CTD
PMID:22079614
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
G
Ccnd2
cyclin D2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCND2 mRNA
CTD
PMID:22079614
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Cd244
CD244 molecule
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CD244 mRNA
CTD
PMID:22079614
NCBI chr13:84,051,339...84,082,864
Ensembl chr13:84,052,493...84,074,492
G
Cd74
CD74 molecule
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CD74 mRNA
CTD
PMID:22079614
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd9
CD9 molecule
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CD9 mRNA
CTD
PMID:22079614
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdh1
cadherin 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDH1 protein
CTD
PMID:32028606
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh22
cadherin 22
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDH22 mRNA
CTD
PMID:22079614
NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588
G
Cdh4
cadherin 4
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDH4 mRNA
CTD
PMID:22079614
NCBI chr 3:166,525,092...167,003,380
Ensembl chr 3:166,525,099...167,003,371
G
Cdh6
cadherin 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CDH6 mRNA
CTD
PMID:22079614
NCBI chr 2:62,079,139...62,225,298
Ensembl chr 2:62,079,137...62,225,228
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDK2 mRNA
CTD
PMID:22079614
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDKN1A mRNA
CTD
PMID:22079614
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdon
cell adhesion associated, oncogene regulated
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CDON mRNA
CTD
PMID:20147733
NCBI chr 8:33,775,123...33,861,635
Ensembl chr 8:33,806,183...33,859,033
G
Cdx1
caudal type homeo box 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDX1 mRNA
CTD
PMID:22079614
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
G
Ceacam6
CEA cell adhesion molecule 6
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEACAM6 mRNA
CTD
PMID:16997883
NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:80,416,531...80,434,668
G
Cebpg
CCAAT/enhancer binding protein gamma
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CEBPG mRNA
CTD
PMID:22079614
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form
CTD
PMID:16709600
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Cga
glycoprotein hormones, alpha polypeptide
increases expression
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CGA mRNA
CTD
PMID:8404651 PMID:21467749 PMID:22079614
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
G
Cgn
cingulin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CGN mRNA
CTD
PMID:22079614
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
G
Chn1
chimerin 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CHN1 mRNA
CTD
PMID:22079614
NCBI chr 3:58,509,822...58,676,462
Ensembl chr 3:58,510,536...58,676,490
G
Chp1
calcineurin-like EF-hand protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CHP1 mRNA
CTD
PMID:22079614
NCBI chr 3:106,536,009...106,571,255
Ensembl chr 3:106,536,004...106,571,251
G
Cidea
cell death-inducing DFFA-like effector a
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CIDEA mRNA
CTD
PMID:22079614
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
G
Cidec
cell death-inducing DFFA-like effector c
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CIDEC protein
CTD
PMID:21097823
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
G
Ckmt2
creatine kinase, mitochondrial 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CKMT2 mRNA
CTD
PMID:22079614
NCBI chr 2:23,079,918...23,110,518
Ensembl chr 2:23,079,918...23,110,430
G
Cldn1
claudin 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CLDN1 mRNA
CTD
PMID:22079614
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn5
claudin 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLDN5 mRNA
CTD
PMID:20711499
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Clgn
calmegin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLGN mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
G
Clic3
chloride intracellular channel 3
multiple interactions increases expression
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CLIC3 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLIC3 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
G
Cmklr1
chemerin chemokine-like receptor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CMKLR1 mRNA
CTD
PMID:20147733
NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129
G
Cnih3
cornichon family AMPA receptor auxiliary protein 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CNIH3 mRNA
CTD
PMID:22079614
NCBI chr13:93,016,707...93,208,168
Ensembl chr13:93,099,784...93,208,121
G
Cnr1
cannabinoid receptor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CNR1 mRNA
CTD
PMID:22079614
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Col15a1
collagen type XV alpha 1 chain
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL15A1 mRNA
CTD
PMID:16997883
NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
G
Col4a4
collagen type IV alpha 4 chain
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL4A4 mRNA
CTD
PMID:22079614
NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876
G
Col4a6
collagen type IV alpha 6 chain
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL4A6 mRNA
CTD
PMID:16997883
NCBI chr X:104,766,463...105,117,499
Ensembl chr X:104,766,957...105,117,500
G
Col6a3
collagen type VI alpha 3 chain
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL6A3 mRNA
CTD
PMID:22079614
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Col7a1
collagen type VII alpha 1 chain
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL7A1 mRNA
CTD
PMID:16997883
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Colec12
collectin sub-family member 12
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of COLEC12 mRNA
CTD
PMID:22079614
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
G
Coro2a
coronin 2A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CORO2A mRNA
CTD
PMID:22079614
NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035
G
Cpm
carboxypeptidase M
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CPM mRNA
CTD
PMID:22079614
NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220
G
Cpo
carboxypeptidase O
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CPO mRNA
CTD
PMID:22079614
NCBI chr 9:65,319,996...65,338,250
G
Cradd
CASP2 and RIPK1 domain containing adaptor with death domain
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CRADD mRNA
CTD
PMID:22079614
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of CREB1 protein
CTD
PMID:18467523
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Testosterone]]
CTD
PMID:2153673
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
G
Crhbp
corticotropin releasing hormone binding protein
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CRHBP mRNA
CTD
PMID:22079614
NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
G
Cst6
cystatin E/M
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CST6 mRNA
CTD
PMID:16997883
NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030
G
Ctnna2
catenin alpha 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTNNA2 mRNA
CTD
PMID:22079614
NCBI chr 4:109,294,249...110,443,409
Ensembl chr 4:109,293,978...110,443,522
G
Cttnbp2
cortactin binding protein 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTTNBP2 mRNA
CTD
PMID:22079614
NCBI chr 4:46,800,975...46,964,681
Ensembl chr 4:46,800,981...46,964,631
G
Cux2
cut-like homeobox 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CUX2 mRNA
CTD
PMID:22079614
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
G
Cx3cl1
C-X3-C motif chemokine ligand 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CX3CL1 mRNA
CTD
PMID:22079614
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL10 mRNA
CTD
PMID:22079614
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CXCL12 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL12 mRNA
CTD
PMID:20711499 PMID:22079614
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cycs
cytochrome c, somatic
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYCS mRNA
CTD
PMID:22079614
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions increases expression increases activity
ISO EXP
2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein]]; [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; Hydrocarbons, Chlorinated inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP11A1 protein 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP11A1 protein]
CTD
PMID:20147733 PMID:21126571 PMID:21610156 PMID:21664964 PMID:21726595 PMID:22546480 PMID:24014645 PMID:24328340 PMID:24740604 PMID:34896276 More...
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
multiple interactions increases expression
ISO
bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B1 mRNA]; Mitotane affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B1 mRNA]
CTD
PMID:22079614 PMID:22172629 PMID:22546480 PMID:34896276
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B2 mRNA
CTD
PMID:22079614 PMID:34896276
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
[4-nitro-3-phenylphenol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of CYP17A1 protein; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]]; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP17A1 mRNA; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]
CTD
PMID:18336853 PMID:21610156 PMID:21726595 PMID:22079614 PMID:22546480 PMID:24014645 PMID:34896276 More...
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
multiple interactions increases expression increases activity
EXP ISO
[vinclozolin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA; Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA]; bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; formestane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; Methoxychlor inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein] [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 protein
CTD
PMID:10746939 PMID:18815356 PMID:21126571 PMID:21610156 PMID:22120136 PMID:23583632 PMID:28859905 PMID:30951242 More...
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 protein
CTD
PMID:7588239 PMID:22079614
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP27A1 mRNA
CTD
PMID:22079614
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP2E1 mRNA
CTD
PMID:22079614
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2f4
cytochrome P450, family 2, subfamily f, polypeptide 4
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP2F1 mRNA
CTD
PMID:22079614
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP3A5 mRNA
CTD
PMID:22079614
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp51
cytochrome P450, family 51
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP51A1 mRNA [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA; [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA]; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein]
CTD
PMID:18467523 PMID:22079614
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP8B1 mRNA
CTD
PMID:22079614
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Cyth1
cytohesin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYTH1 mRNA
CTD
PMID:22079614
NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760
G
Dach2
dachshund family transcription factor 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DACH2 mRNA
CTD
PMID:22079614
NCBI chr X:78,718,963...79,018,023
Ensembl chr X:78,451,593...79,017,592
G
Dact1
dishevelled-binding antagonist of beta-catenin 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DACT1 mRNA
CTD
PMID:22079614
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
G
Dcaf12l1
DDB1 and CUL4 associated factor 12-like 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DCAF12L1 mRNA
CTD
PMID:22079614
NCBI chr X:123,695,286...123,698,905
Ensembl chr X:123,695,286...123,698,905
G
Dcbld2
discoidin, CUB and LCCL domain containing 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DCBLD2 mRNA
CTD
PMID:22079614
NCBI chr11:42,125,525...42,179,927
Ensembl chr11:42,125,787...42,179,697
G
Dgat2
diacylglycerol O-acyltransferase 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DGAT2 mRNA
CTD
PMID:22079614
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dgkb
diacylglycerol kinase, beta
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DGKB mRNA
CTD
PMID:22079614
NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DHCR24 mRNA
CTD
PMID:22079614
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DHCR7 mRNA
CTD
PMID:22079614
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dhrs2
dehydrogenase/reductase 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DHRS2 mRNA
CTD
PMID:22079614
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
G
Dhrs3
dehydrogenase/reductase 3
multiple interactions
ISO
7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]
CTD
PMID:23275455
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dio2
iodothyronine deiodinase 2
multiple interactions increases activity
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased activity of DIO2 protein 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]]; Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]]
CTD
PMID:11425850 PMID:18420745
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dio3
iodothyronine deiodinase 3
multiple interactions
EXP
Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Sodium Selenite] promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Hydrogen Peroxide promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]
CTD
PMID:18420745
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DKK1 mRNA
CTD
PMID:22079614
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Dnah5
dynein, axonemal, heavy chain 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNAH5 mRNA
CTD
PMID:22079614
NCBI chr 2:78,937,788...79,255,551
Ensembl chr 2:78,937,800...79,254,890
G
Dnajb3
DnaJ heat shock protein family (Hsp40) member B3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DNAJB3 mRNA
CTD
PMID:22079614
NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560
G
Dnajb7
DnaJ heat shock protein family (Hsp40) member B7
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNAJB7 mRNA
CTD
PMID:22079614
NCBI chr 7:112,932,736...112,934,050
Ensembl chr 7:112,932,616...112,945,537
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNAJB9 mRNA
CTD
PMID:22079614
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
G
Dner
delta/notch-like EGF repeat containing
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNER mRNA
CTD
PMID:22079614
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
G
Dock11
dedicator of cytokinesis 11
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DOCK11 mRNA
CTD
PMID:22079614
NCBI chr X:115,131,720...115,314,854
Ensembl chr X:115,131,909...115,314,854
G
Dok5
docking protein 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DOK5 mRNA
CTD
PMID:22079614
NCBI chr 3:159,515,886...159,652,811
Ensembl chr 3:159,515,893...159,652,810
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DUSP1 mRNA
CTD
PMID:22079614
NCBI chr10:16,680,478...16,683,275
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DUSP16 mRNA
CTD
PMID:22079614
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
G
Dusp4
dual specificity phosphatase 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DUSP4 mRNA
CTD
PMID:20147733
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DUSP6 mRNA
CTD
PMID:22079614
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Ebp
EBP, cholestenol delta-isomerase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EBP mRNA
CTD
PMID:22079614
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
G
Echs1
enoyl-CoA hydratase, short chain 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ECHS1 mRNA
CTD
PMID:22079614
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Egf
epidermal growth factor
multiple interactions
ISO
EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]]
CTD
PMID:18467523
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGFR mRNA
CTD
PMID:22079614
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR1 mRNA
CTD
PMID:22079614
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr2
early growth response 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR2 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Elp1
elongator acetyltransferase complex subunit 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ELP1 mRNA
CTD
PMID:22079614
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
G
Emp2
epithelial membrane protein 2
multiple interactions decreases expression
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of EMP2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EMP2 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
G
Enox1
ecto-NOX disulfide-thiol exchanger 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ENOX1 mRNA
CTD
PMID:20147733
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
G
Ep300
E1A binding protein p300
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EP300 mRNA
CTD
PMID:22079614
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epg5
ectopic P-granules 5 autophagy tethering factor
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EPG5 mRNA
CTD
PMID:20147733
NCBI chr18:71,403,990...71,502,079
Ensembl chr18:71,404,010...71,501,502
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EPHX1 mRNA
CTD
PMID:22079614
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Erap1
endoplasmic reticulum aminopeptidase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ERAP1 mRNA
CTD
PMID:22079614
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
G
Erf
Ets2 repressor factor
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ERF mRNA
CTD
PMID:22079614
NCBI chr 1:80,829,935...80,838,388
Ensembl chr 1:80,829,935...80,838,388
G
Esr2
estrogen receptor 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ESR2 mRNA
CTD
PMID:22079614
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Esrra
estrogen related receptor, alpha
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ESRRA mRNA
CTD
PMID:23166782
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
G
Esrrg
estrogen-related receptor gamma
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ESRRG mRNA
CTD
PMID:22079614
NCBI chr13:99,167,656...99,788,016
Ensembl chr13:99,564,669...99,783,397
G
Etnppl
ethanolamine-phosphate phospho-lyase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ETNPPL mRNA
CTD
PMID:22079614
NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212
G
Etv1
ETS variant transcription factor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ETV1 mRNA
CTD
PMID:20147733
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
G
Etv5
ETS variant transcription factor 5
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ETV5 mRNA
CTD
PMID:22079614
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EZH2 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EZH2 protein [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]
CTD
PMID:21903722
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
F2rl2
coagulation factor II (thrombin) receptor-like 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of F2RL2 mRNA
CTD
PMID:20147733
NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098
G
Fabp1
fatty acid binding protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FABP1 mRNA
CTD
PMID:22079614
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Fads1
fatty acid desaturase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FADS1 mRNA
CTD
PMID:22079614
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Faslg
Fas ligand
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein
CTD
PMID:16709600
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbln1
fibulin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FBLN1 mRNA
CTD
PMID:15774544
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbxo32
F-box protein 32
multiple interactions
ISO
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA]
CTD
PMID:23275455
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDFT1 mRNA
CTD
PMID:22079614
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
G
Fdx1
ferredoxin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDX1 mRNA
CTD
PMID:22079614
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
G
Fdxr
ferredoxin reductase
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDXR protein Hydrocarbons, Chlorinated inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDXR protein]
CTD
PMID:24740604
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fer1l6
fer-1-like family member 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FER1L6 mRNA
CTD
PMID:20147733
NCBI chr 7:90,093,567...90,216,907
Ensembl chr 7:90,061,924...90,215,214
G
Fgf10
fibroblast growth factor 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FGF10 mRNA
CTD
PMID:20147733
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgf13
fibroblast growth factor 13
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FGF13 mRNA
CTD
PMID:22079614
NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391
G
Fgf9
fibroblast growth factor 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FGF9 mRNA
CTD
PMID:22079614
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FHL2 mRNA
CTD
PMID:22079614
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Flot1
flotillin 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FLOT1 mRNA
CTD
PMID:16997883
NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978
G
Flot2
flotillin 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FLOT2 mRNA
CTD
PMID:22079614
NCBI chr10:62,926,047...62,947,759
Ensembl chr10:62,920,665...62,947,756
G
Fn1
fibronectin 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FN1 mRNA
CTD
PMID:22079614
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Foxo1
forkhead box O1
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 protein; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein]; Hydrogen Peroxide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 mRNA]; Hydrogen Peroxide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 protein]
CTD
PMID:16709600
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Foxo3
forkhead box O3
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] inhibits the reaction [Hydrogen Peroxide results in increased expression of FOXO3 mRNA]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] inhibits the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA]
CTD
PMID:16709600
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Foxr1
forkhead box R1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FOXR1 mRNA
CTD
PMID:22079614
NCBI chr 8:44,760,587...44,768,696
Ensembl chr 8:44,760,948...44,768,880
G
Fras1
Fraser extracellular matrix complex subunit 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FRAS1 mRNA
CTD
PMID:22079614
NCBI chr14:12,791,407...13,200,862
Ensembl chr14:12,793,599...13,200,726
G
Fshb
follicle stimulating hormone subunit beta
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FSHB mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FSHB protein Tetrachlorodibenzodioxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FSHB mRNA]
CTD
PMID:8404651 PMID:10746652 PMID:21467749
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Fzd10
frizzled class receptor 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FZD10 mRNA
CTD
PMID:22079614
NCBI chr12:28,098,371...28,101,566
Ensembl chr12:28,098,371...28,101,566
G
Fzd4
frizzled class receptor 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FZD4 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
G
Fzd7
frizzled class receptor 7
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FZD7 mRNA
CTD
PMID:22079614
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GABBR2 mRNA
CTD
PMID:22079614
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
G
Gabra4
gamma-aminobutyric acid type A receptor subunit alpha 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GABRA4 mRNA
CTD
PMID:22079614
NCBI chr14:36,590,782...36,667,724
Ensembl chr14:36,590,782...36,665,844
G
Gabrg1
gamma-aminobutyric acid type A receptor subunit gamma 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GABRG1 mRNA
CTD
PMID:22079614
NCBI chr14:37,396,217...37,469,606
Ensembl chr14:37,396,294...37,635,956
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of GADD45A mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of GADD45A protein
CTD
PMID:16709600
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galnt12
polypeptide N-acetylgalactosaminyltransferase 12
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GALNT12 mRNA
CTD
PMID:20147733
NCBI chr 5:61,384,575...61,413,346
Ensembl chr 5:61,384,571...61,413,354
G
Galr1
galanin receptor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GALR1 mRNA
CTD
PMID:22079614
NCBI chr18:75,772,021...75,787,577
Ensembl chr18:75,772,023...75,787,577
G
Gap43
growth associated protein 43
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GAP43 mRNA
CTD
PMID:20147733
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gck
glucokinase
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GCK mRNA
CTD
PMID:22079614
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gcsam
germinal center-associated, signaling and motility
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GCSAM mRNA
CTD
PMID:22079614
NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992
G
Gdf10
growth differentiation factor 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GDF10 mRNA
CTD
PMID:22079614
NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343
G
Gdf15
growth differentiation factor 15
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GDF15 mRNA
CTD
PMID:22079614
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gfap
glial fibrillary acidic protein
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFAP mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]
CTD
PMID:15994020
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFPT2 mRNA
CTD
PMID:20147733
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Gimap8
GTPase, IMAP family member 8
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GIMAP8 mRNA
CTD
PMID:22079614
NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:77,600,186...77,611,590
G
Gja1
gap junction protein, alpha 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GJA1 mRNA
CTD
PMID:22079614
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjb2
gap junction protein, beta 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GJB2 mRNA
CTD
PMID:22079614
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gk
glycerol kinase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GK mRNA
CTD
PMID:22079614
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLIPR1 mRNA
CTD
PMID:20147733
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glrx
glutaredoxin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLRX mRNA
CTD
PMID:22079614
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gnai2
G protein subunit alpha i2
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]
CTD
PMID:19252090
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]
CTD
PMID:19252090
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
G
Gng2
G protein subunit gamma 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GNG2 mRNA
CTD
PMID:22079614
NCBI chr15:4,316,038...4,416,918
Ensembl chr15:4,316,059...4,417,183
G
Gpr22
G protein-coupled receptor 22
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GPR22 mRNA
CTD
PMID:22079614
NCBI chr 6:48,309,619...48,317,864
Ensembl chr 6:48,310,505...48,317,486
G
Gpr37
G protein-coupled receptor 37
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GPR37 mRNA
CTD
PMID:22079614
NCBI chr 4:54,138,860...54,160,927
Ensembl chr 4:54,138,870...54,161,001
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GPX1 mRNA
CTD
PMID:22079614
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GRB10 mRNA
CTD
PMID:22079614
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
G
Grb14
growth factor receptor bound protein 14
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GRB14 mRNA
CTD
PMID:22079614
NCBI chr 3:49,568,210...49,683,805
Ensembl chr 3:49,568,210...49,683,889
G
Grem2
gremlin 2, DAN family BMP antagonist
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GREM2 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
ISO
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]
CTD
PMID:23275455
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Grin3a
glutamate ionotropic receptor NMDA type subunit 3A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GRIN3A mRNA
CTD
PMID:22079614
NCBI chr 5:64,006,847...64,206,408
Ensembl chr 5:64,009,980...64,206,085
G
Gsta2
glutathione S-transferase alpha 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GSTA2 mRNA
CTD
PMID:22079614
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gstm2
glutathione S-transferase mu 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GSTM2 mRNA
CTD
PMID:22079614
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GSTM4 mRNA
CTD
PMID:20147733
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
G
Has2
hyaluronan synthase 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HAS2 mRNA
CTD
PMID:20147733
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Hbg1
hemoglobin subunit gamma 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HBG1 mRNA
CTD
PMID:22079614
NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:158,271,873...158,273,425
G
Hdac3
histone deacetylase 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HDAC3 mRNA
CTD
PMID:22079614
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
G
Hdac5
histone deacetylase 5
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HDAC5 mRNA
CTD
PMID:22079614
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
G
Hey2
hes-related family bHLH transcription factor with YRPW motif 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HEY2 mRNA
CTD
PMID:22079614
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
G
Hlf
HLF transcription factor, PAR bZIP family member
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HLF mRNA
CTD
PMID:22079614
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
G
Hmga1
high mobility group AT-hook 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMGA1 mRNA
CTD
PMID:22079614
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMGCS1 mRNA
CTD
PMID:22079614
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMOX1 mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMOX1 mRNA]
CTD
PMID:15179140 PMID:15994020
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf4g
hepatocyte nuclear factor 4, gamma
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HNF4G mRNA
CTD
PMID:22079614
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
G
Hoxb9
homeo box B9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HOXB9 mRNA
CTD
PMID:22079614
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
G
Hpca
hippocalcin
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HPCA mRNA
CTD
PMID:22079614
NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841
G
Hs3st1
heparan sulfate-glucosamine 3-sulfotransferase 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HS3ST1 mRNA
CTD
PMID:22079614
NCBI chr14:71,185,826...71,223,263
Ensembl chr14:71,185,682...71,223,248
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions
ISO
4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of and results in increased activity of HSD11B1 protein; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of HSD11B1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA; Hydrocortisone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]
CTD
PMID:23275455
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
decreases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD11B2 mRNA [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B2 protein
CTD
PMID:22079614 PMID:23275455
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
multiple interactions increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [bisphenol A results in decreased expression of HSD17B1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B1 mRNA
CTD
PMID:18815356 PMID:21273127
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
G
Hsd17b14
hydroxysteroid (17-beta) dehydrogenase 14
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD17B14 mRNA
CTD
PMID:22079614
NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
multiple interactions increases expression
ISO
bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA] [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] affects the expression of HSD17B2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 protein
CTD
PMID:18815356 PMID:21273127 PMID:21610156
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B3 mRNA
CTD
PMID:22079614
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
multiple interactions
ISO
[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein
CTD
PMID:18336853
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B7 mRNA
CTD
PMID:22079614
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
multiple interactions decreases expression increases expression
ISO
2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]]; Triiodothyronine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD3B1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 protein
CTD
PMID:18815356 PMID:21726595 PMID:22079614
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B2 mRNA [4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of HSD3B2 protein; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B2 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B2 mRNA]
CTD
PMID:18336853 PMID:22079614 PMID:22546480 PMID:34896276
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSP90AA1 mRNA
CTD
PMID:22079614
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSPA1A mRNA
CTD
PMID:22079614
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSPA5 mRNA
CTD
PMID:22079614
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSPA8 mRNA
CTD
PMID:22079614
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSPH1 mRNA
CTD
PMID:22079614
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of ICAM1 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]
CTD
PMID:10495789
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icam2
intercellular adhesion molecule 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ICAM2 mRNA
CTD
PMID:22079614
NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293
G
Id1
inhibitor of DNA binding 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ID1 mRNA
CTD
PMID:22079614
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Idi1
isopentenyl-diphosphate delta isomerase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IDI1 mRNA
CTD
PMID:22079614
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
G
Ier3
immediate early response 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IER3 mRNA
CTD
PMID:20147733
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Igf1
insulin-like growth factor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGF1 mRNA
CTD
PMID:20147733
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGF2BP2 mRNA
CTD
PMID:22079614
NCBI chr11:78,874,402...78,974,392
Ensembl chr11:78,874,414...78,974,377
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions increases expression decreases expression increases secretion
ISO
1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; 4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein; Dexamethasone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein]; Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]]; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 protein 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 protein 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of IGFBP1 protein
CTD
PMID:16709600 PMID:17065600 PMID:18815356 PMID:20147733 PMID:21273127 PMID:21903722 PMID:23275455 More...
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP5 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Ikzf1
IKAROS family zinc finger 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IKZF1 mRNA
CTD
PMID:22079614
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il18
interleukin 18
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL18 mRNA
CTD
PMID:22079614
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
multiple interactions increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL1A mRNA
CTD
PMID:11230753 PMID:22079614
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]
CTD
PMID:11112151
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il27ra
interleukin 27 receptor subunit alpha
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL27RA mRNA
CTD
PMID:22079614
NCBI chr19:24,109,963...24,121,977
Ensembl chr19:24,109,972...24,121,938
G
Il4
interleukin 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL4 mRNA
CTD
PMID:22079614
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL4R mRNA
CTD
PMID:20147733
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
multiple interactions
ISO EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of IL6 mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:16997883 PMID:21803157
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL7R mRNA
CTD
PMID:22079614
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Inhba
inhibin subunit beta A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INHBA mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Insig1
insulin induced gene 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INSIG1 mRNA
CTD
PMID:22079614
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insm2
INSM transcriptional repressor 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INSM2 mRNA
CTD
PMID:22079614
NCBI chr 6:72,973,861...72,976,453
G
Iqgap2
IQ motif containing GTPase activating protein 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IQGAP2 mRNA
CTD
PMID:22079614
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
G
Irs1
insulin receptor substrate 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IRS1 mRNA
CTD
PMID:22079614
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
G
Ism1
isthmin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ISM1 mRNA
CTD
PMID:20147733
NCBI chr 3:127,023,296...127,102,228
Ensembl chr 3:127,021,865...127,101,894
G
Itga2
integrin subunit alpha 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ITGA2 mRNA
CTD
PMID:20147733
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itpkb
inositol-trisphosphate 3-kinase B
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ITPKB mRNA
CTD
PMID:22079614
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
G
Jag1
jagged canonical Notch ligand 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of JAG1 mRNA
CTD
PMID:22079614
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Jarid2
jumonji and AT-rich interaction domain containing 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of JARID2 mRNA
CTD
PMID:20147733
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased phosphorylation of JUN protein
CTD
PMID:28697429
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of JUND mRNA
CTD
PMID:22079614
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kcnc2
potassium voltage-gated channel subfamily C member 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCNC2 mRNA
CTD
PMID:22079614
NCBI chr 7:47,700,035...47,883,979
Ensembl chr 7:47,700,288...47,883,968
G
Kcnd2
potassium voltage-gated channel subfamily D member 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCND2 mRNA
CTD
PMID:22079614
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
G
Kcne4
potassium voltage-gated channel subfamily E regulatory subunit 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCNE4 mRNA
CTD
PMID:22079614
NCBI chr 9:80,243,429...80,251,533
Ensembl chr 9:80,247,379...80,250,979
G
Kcnh6
potassium voltage-gated channel subfamily H member 6
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCNH6 mRNA
CTD
PMID:22079614
NCBI chr10:90,949,240...90,970,746
Ensembl chr10:90,949,846...90,970,701
G
Kcnq1
potassium voltage-gated channel subfamily Q member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCNQ1 mRNA
CTD
PMID:22079614
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
G
Kctd12
potassium channel tetramerization domain containing 12
multiple interactions increases expression decreases expression
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of KCTD12 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCTD12 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCTD12 mRNA
CTD
PMID:16997883 PMID:20147733 PMID:22079614
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
G
Kif5c
kinesin family member 5C
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KIF5C mRNA
CTD
PMID:22079614
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
G
Kirrel3
kirre like nephrin family adhesion molecule 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KIRREL3 mRNA
CTD
PMID:22079614
NCBI chr 8:32,865,779...33,407,555
Ensembl chr 8:32,862,776...33,405,676
G
Klhl5
kelch-like family member 5
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KLHL5 mRNA
CTD
PMID:22079614
NCBI chr14:43,144,254...43,206,192
Ensembl chr14:43,144,257...43,184,238
G
Klrc1
killer cell lectin like receptor C1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KLRC1 mRNA
CTD
PMID:22079614
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
G
Klrc2
killer cell lectin like receptor C2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KLRC2 mRNA
CTD
PMID:22079614
NCBI chr 4:163,122,700...163,133,843
Ensembl chr 4:163,122,704...163,133,843
G
Klrc3
killer cell lectin like receptor C3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KLRC3 mRNA
CTD
PMID:22079614
NCBI chr 4:163,105,081...163,112,737
Ensembl chr 4:163,106,024...163,112,336
G
Krt34
keratin 34
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KRT34 mRNA
CTD
PMID:20147733
NCBI chr10:84,969,988...84,974,098
Ensembl chr10:84,970,017...84,974,040
G
Krtap1-1
keratin associated protein 1-1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KRTAP1-5 mRNA
CTD
PMID:20147733
NCBI chr10:84,545,765...84,546,331
Ensembl chr10:84,545,580...84,546,354
G
L3mbtl3
L3MBTL histone methyl-lysine binding protein 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of L3MBTL3 mRNA
CTD
PMID:22079614
NCBI chr 1:18,988,763...19,089,247
Ensembl chr 1:18,990,618...19,089,263
G
Lama3
laminin subunit alpha 3
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMA3 mRNA
CTD
PMID:16997883
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
G
Lamb3
laminin subunit beta 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LAMB3 mRNA
CTD
PMID:22079614
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lamp3
lysosomal-associated membrane protein 3
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMP3 mRNA
CTD
PMID:16997883
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Lat2
linker for activation of T cells family, member 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LAT2 mRNA
CTD
PMID:22079614
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LDLR mRNA
CTD
PMID:22079614
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lef1
lymphoid enhancer binding factor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LEF1 mRNA
CTD
PMID:22079614
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
G
Lep
leptin
multiple interactions decreases response to substance
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]; LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; SB 203580 inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]] LEP protein results in decreased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate
CTD
PMID:19849856
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
multiple interactions
ISO
LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]
CTD
PMID:19849856
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lgals1
galectin 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LGALS1 mRNA
CTD
PMID:22079614
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lgr4
leucine-rich repeat-containing G protein-coupled receptor 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LGR4 mRNA
CTD
PMID:20147733
NCBI chr 3:96,447,385...96,550,006
Ensembl chr 3:96,447,858...96,548,899
G
Lhb
luteinizing hormone subunit beta
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHB mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHB protein 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Testosterone]]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [CGB3 protein results in increased chemical synthesis of Testosterone]]; Tetrachlorodibenzodioxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHB mRNA]
CTD
PMID:2153673 PMID:8404651 PMID:21467749
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
decreases expression increases expression multiple interactions
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LHCGR mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHCGR mRNA T-2 Toxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHCGR mRNA] Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHCGR mRNA]
CTD
PMID:22079614 PMID:23583632 PMID:30951242
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
G
Lif
LIF, interleukin 6 family cytokine
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LIF mRNA [NR5A1 protein co-treated with LIF protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Tretinoin] results in increased abundance of Progesterone
CTD
PMID:16997883 PMID:21610156
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Limch1
LIM and calponin homology domains 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LIMCH1 mRNA
CTD
PMID:16997883
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
G
Lingo1
leucine rich repeat and Ig domain containing 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LINGO1 mRNA
CTD
PMID:22079614
NCBI chr 8:57,011,272...57,193,496
Ensembl chr 8:57,010,007...57,196,544
G
Lipc
lipase C, hepatic type
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LIPC mRNA
CTD
PMID:22079614
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lmnb1
lamin B1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LMNB1 mRNA
CTD
PMID:22079614
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lmo3
LIM domain only 3
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LMO3 mRNA
CTD
PMID:16997883
NCBI chr 4:171,234,686...171,297,677
Ensembl chr 4:171,234,696...171,292,222
G
Loxl1
lysyl oxidase-like 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LOXL1 mRNA
CTD
PMID:16997883
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lpcat1
lysophosphatidylcholine acyltransferase 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPCAT1 mRNA
CTD
PMID:16997883
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
G
Lpl
lipoprotein lipase
increases expression decreases activity
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LPL mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased activity of LPL protein
CTD
PMID:9032464 PMID:9414485
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrrc17
leucine rich repeat containing 17
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LRRC17 mRNA
CTD
PMID:22079614
NCBI chr 4:13,501,428...13,531,845
Ensembl chr 4:13,501,436...13,531,845
G
Lss
lanosterol synthase
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LSS mRNA
CTD
PMID:22079614
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Lum
lumican
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LUM mRNA
CTD
PMID:22079614
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Lxn
latexin
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LXN mRNA
CTD
PMID:16997883
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
G
Lypd1
Ly6/Plaur domain containing 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LYPD1 mRNA
CTD
PMID:20147733
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
G
Lyve1
lymphatic vessel endothelial hyaluronan receptor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of XLKD1 mRNA
CTD
PMID:22079614
NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309
G
Mamdc2
MAM domain containing 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAMDC2 mRNA
CTD
PMID:22079614
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
G
Man1a1
mannosidase, alpha, class 1A, member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAN1A1 mRNA
CTD
PMID:22079614
NCBI chr20:33,202,509...33,385,747
Ensembl chr20:33,202,517...33,385,824
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAP3K8 mRNA
CTD
PMID:22079614
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO EXP
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK1 protein]; [1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK1 protein [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein; azalanstat inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein] 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:8526880 PMID:12657697 PMID:18467523 PMID:19252090
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk10
mitogen activated protein kinase 10
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPK10 mRNA
CTD
PMID:22079614
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases expression
ISO EXP
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK3 protein]; [1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK3 protein [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein; azalanstat inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]]; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein] 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPK3 mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:8526880 PMID:12657697 PMID:18467523 PMID:19252090 PMID:22079614
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPT mRNA
CTD
PMID:22079614
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mc2r
melanocortin 2 receptor
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MC2R mRNA [20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] promotes the reaction [NR5A1 protein binds to MC2R promoter]
CTD
PMID:21610156 PMID:22079614
NCBI chr18:62,001,980...62,015,567
Ensembl chr18:62,004,948...62,015,488
G
Mcf2
MCF.2 cell line derived transforming sequence
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MCF2 mRNA
CTD
PMID:22079614
NCBI chr X:138,414,077...138,514,828
Ensembl chr X:138,409,256...138,514,446
G
Mcf2l
MCF.2 cell line derived transforming sequence-like
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MCF2L mRNA
CTD
PMID:22079614
NCBI chr16:76,507,133...76,652,893
Ensembl chr16:76,507,133...76,652,733
G
Mdh1
malate dehydrogenase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MDH1 mRNA
CTD
PMID:22079614
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Medag
mesenteric estrogen-dependent adipogenesis
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MEDAG mRNA
CTD
PMID:20147733
NCBI chr12:5,613,191...5,634,583
Ensembl chr12:5,613,208...5,634,767
G
Mertk
MER proto-oncogene, tyrosine kinase
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MERTK mRNA
CTD
PMID:22079614
NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554
G
Metrnl
meteorin-like, glial cell differentiation regulator
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of METRNL mRNA
CTD
PMID:22079614
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MGST1 mRNA
CTD
PMID:22079614
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mia2
MIA SH3 domain ER export factor 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MIA2 mRNA
CTD
PMID:22079614
NCBI chr 6:76,787,508...76,885,246
Ensembl chr 6:76,787,508...76,885,211
G
Micb
MHC class I polypeptide-related sequence B
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MICB mRNA
CTD
PMID:22079614
NCBI chr 1:78,495,779...78,513,030
Ensembl chr 1:78,495,779...78,512,827
G
Milr1
mast cell immunoglobulin-like receptor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MILR1 mRNA
CTD
PMID:20147733
NCBI chr10:91,684,288...91,705,284
Ensembl chr10:91,687,831...91,705,282
G
Mme
membrane metallo-endopeptidase
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MME mRNA
CTD
PMID:22079614
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MMP10 mRNA
CTD
PMID:22079614
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp16
matrix metallopeptidase 16
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MMP16 mRNA
CTD
PMID:20147733
NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388
G
Mob4
MOB family member 4, phocein
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MOB4 mRNA
CTD
PMID:22079614
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
G
Mocos
molybdenum cofactor sulfurase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MOCOS mRNA
CTD
PMID:22079614
NCBI chr18:15,931,659...15,977,415
Ensembl chr18:15,931,654...15,977,187
G
Moxd1
monooxygenase, DBH-like 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MOXD1 mRNA
CTD
PMID:22079614
NCBI chr 1:21,075,124...21,165,348
Ensembl chr 1:21,075,122...21,161,779
G
Mpp3
MAGUK p55 scaffold protein 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MPP3 mRNA
CTD
PMID:22079614
NCBI chr10:86,945,705...86,975,261
Ensembl chr10:86,945,714...86,974,737
G
Mrap
melanocortin 2 receptor accessory protein
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MRAP mRNA
CTD
PMID:22079614
NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
G
Mras
muscle RAS oncogene homolog
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MRAS mRNA
CTD
PMID:22079614
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
G
Msmo1
methylsterol monooxygenase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MSMO1 mRNA
CTD
PMID:22079614
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msrb3
methionine sulfoxide reductase B3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MSRB3 mRNA
CTD
PMID:22079614
NCBI chr 7:56,260,985...56,426,004
Ensembl chr 7:56,303,308...56,425,496
G
Mtmr4
myotubularin related protein 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MTMR4 mRNA
CTD
PMID:20147733
NCBI chr10:72,393,411...72,416,342
Ensembl chr10:72,392,551...72,416,342
G
Mtss1
MTSS I-BAR domain containing 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MTSS1 mRNA
CTD
PMID:22079614
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
G
Muc1
mucin 1, cell surface associated
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of MUC1 mRNA
CTD
PMID:16997883
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Mug2
murinoglobulin 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PZP mRNA
CTD
PMID:22079614
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
G
Mvd
mevalonate diphosphate decarboxylase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MVD mRNA
CTD
PMID:22079614
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
G
Mvk
mevalonate kinase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MVK mRNA
CTD
PMID:22079614
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
G
Myb
MYB proto-oncogene, transcription factor
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYB mRNA
CTD
PMID:22079614
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYC mRNA
CTD
PMID:22079614
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myh7b
myosin heavy chain 7B
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYH7B mRNA
CTD
PMID:22079614
NCBI chr 3:144,076,911...144,122,714
Ensembl chr 3:144,098,190...144,122,084
G
Mylip
myosin regulatory light chain interacting protein
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYLIP mRNA
CTD
PMID:22079614
NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295
G
Myof
myoferlin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYOF mRNA
CTD
PMID:22079614
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
G
Mypn
myopalladin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYPN mRNA
CTD
PMID:22079614
NCBI chr20:25,429,898...25,522,443
Ensembl chr20:25,436,843...25,522,443
G
N4bp2l1
NEDD4 binding protein 2-like 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of N4BP2L1 mRNA
CTD
PMID:22079614
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
Nalf1
NALCN channel auxiliary factor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NALF1 mRNA
CTD
PMID:22079614
NCBI chr16:79,713,577...80,236,295
Ensembl chr16:79,713,724...80,235,120
G
Nanos1
nanos C2HC-type zinc finger 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NANOS1 mRNA
CTD
PMID:22079614
NCBI chr 1:259,897,663...259,901,561
Ensembl chr 1:259,897,939...259,898,730
G
Nap1l2
nucleosome assembly protein 1-like 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NAP1L2 mRNA
CTD
PMID:22079614
NCBI chr X:68,174,051...68,176,449
Ensembl chr X:68,173,987...68,176,666
G
Nav3
neuron navigator 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NAV3 mRNA
CTD
PMID:22079614
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
G
Ncf2
neutrophil cytosolic factor 2
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of NCF2 mRNA
CTD
PMID:16997883
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Nectin3
nectin cell adhesion molecule 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NECTIN3 mRNA
CTD
PMID:22079614
NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519
G
Nek6
NIMA-related kinase 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NEK6 mRNA
CTD
PMID:22079614
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Ngef
neuronal guanine nucleotide exchange factor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NGEF mRNA
CTD
PMID:22079614
NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914
G
Ngf
nerve growth factor
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NGF mRNA
CTD
PMID:22079614
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Niban1
niban apoptosis regulator 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NIBAN1 mRNA
CTD
PMID:22079614
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nid2
nidogen 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NID2 mRNA
CTD
PMID:20147733
NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843
G
Nkx2-1
NK2 homeobox 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of NKX2-1 mRNA
CTD
PMID:16997883
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
G
Nmu
neuromedin U
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NMU mRNA
CTD
PMID:23423171
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA]
CTD
PMID:15994020
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch3
notch receptor 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NOTCH3 mRNA
CTD
PMID:20147733
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NR1D1 mRNA
CTD
PMID:22079614
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NR1D2 mRNA
CTD
PMID:22079614
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NR1H2 mRNA
CTD
PMID:22079614
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of NR1H4 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of NR1H4 protein]
CTD
PMID:27743861
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR1I2 mRNA
CTD
PMID:22079614
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR1I3 mRNA
CTD
PMID:22079614
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of NR3C1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of ZNF486 mRNA]; NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA]
CTD
PMID:23275455
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR3C2 mRNA [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of NR3C2 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA]
CTD
PMID:22079614 PMID:23275455
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 protein 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 mRNA
CTD
PMID:21726595 PMID:22079614
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A2 mRNA
CTD
PMID:22079614
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A3 mRNA
CTD
PMID:22079614
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Nr5a1
nuclear receptor subfamily 5, group A, member 1
multiple interactions
ISO
[20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] promotes the reaction [NR5A1 protein binds to MC2R promoter]; [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Progesterone; [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] affects the expression of HSD17B2 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Estradiol; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Progesterone; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Testosterone; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11B1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP17A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP21A1 mRNA; [NR5A1 protein co-treated with LIF protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Tretinoin] results in increased abundance of Progesterone
CTD
PMID:21610156
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
G
Nrcam
neuronal cell adhesion molecule
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NRCAM mRNA
CTD
PMID:22079614
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
G
Nrp1
neuropilin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NRP1 mRNA
CTD
PMID:22079614
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Ntf4
neurotrophin 4
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NTF5 mRNA
CTD
PMID:22079614
NCBI chr 1:95,893,560...95,896,391
Ensembl chr 1:95,893,457...95,897,243
G
Nxn
nucleoredoxin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NXN mRNA
CTD
PMID:22079614
NCBI chr10:61,109,322...61,247,578
Ensembl chr10:61,110,020...61,248,251
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OGT mRNA
CTD
PMID:22079614
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Omg
oligodendrocyte-myelin glycoprotein
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OMG mRNA
CTD
PMID:22079614
NCBI chr10:64,461,350...64,464,084
Ensembl chr10:64,461,350...64,464,084
G
Osbp2
oxysterol binding protein 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of OSBP2 mRNA
CTD
PMID:22079614
NCBI chr14:78,585,088...78,746,785
Ensembl chr14:78,585,089...78,746,786
G
Ostf1
osteoclast stimulating factor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of OSTF1 mRNA
CTD
PMID:22079614
NCBI chr 1:216,002,037...216,049,226
Ensembl chr 1:216,002,044...216,049,221
G
Oxgr1
oxoglutarate receptor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OXGR1 mRNA
CTD
PMID:22079614
NCBI chr15:97,145,947...97,146,960
Ensembl chr15:97,144,293...97,166,612
G
P4ha3
prolyl 4-hydroxylase subunit alpha 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of P4HA3 mRNA
CTD
PMID:20147733
NCBI chr 1:154,628,723...154,663,779
Ensembl chr 1:154,628,736...154,663,775
G
Pakap
paralemmin A kinase anchor protein
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALM2AKAP2 mRNA
CTD
PMID:22079614
NCBI chr 5:72,536,986...72,648,524 NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524
G
Palmd
palmdelphin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALMD mRNA
CTD
PMID:20147733
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
G
Pappa
pappalysin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PAPPA mRNA
CTD
PMID:20147733
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PAPSS2 mRNA
CTD
PMID:22079614
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Paqr5
progestin and adipoQ receptor family member 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PAQR5 mRNA
CTD
PMID:20147733
NCBI chr 8:62,431,867...62,513,688
Ensembl chr 8:62,431,867...62,513,688
G
Patj
PATJ, crumbs cell polarity complex component
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PATJ mRNA
CTD
PMID:22079614
NCBI chr 5:113,061,985...113,364,807
Ensembl chr 5:113,062,118...113,364,807
G
Pbx4
PBX homeobox 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PBX4 mRNA
CTD
PMID:22079614
NCBI chr16:19,555,089...19,590,054
Ensembl chr16:19,555,090...19,590,014
G
Pcdh20
protocadherin 20
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PCDH20 mRNA
CTD
PMID:22079614
NCBI chr15:64,425,534...64,431,790
Ensembl chr15:64,425,534...64,431,790
G
Pcdhb5
protocadherin beta 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PCDHB4 mRNA
CTD
PMID:20147733
NCBI chr18:29,024,315...29,032,183
Ensembl chr18:29,028,382...29,053,259
G
Pcsk1
proprotein convertase subtilisin/kexin type 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PCSK1 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
G
Pde1a
phosphodiesterase 1A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDE1A mRNA
CTD
PMID:20147733
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pde2a
phosphodiesterase 2A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDE2A mRNA
CTD
PMID:22079614
NCBI chr 1:155,823,590...155,915,434
Ensembl chr 1:155,813,180...155,915,434
G
Pde3a
phosphodiesterase 3A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDE3A mRNA
CTD
PMID:12466227
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pdgfd
platelet derived growth factor D
decreases expression increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDGFD mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDGFD mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
G
Pdlim4
PDZ and LIM domain 4
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of PDLIM4 mRNA
CTD
PMID:16997883
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
G
Pdzrn3
PDZ domain containing RING finger 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDZRN3 mRNA
CTD
PMID:22079614
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
G
Pecam1
platelet and endothelial cell adhesion molecule 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PECAM1 mRNA
CTD
PMID:16997883
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Peg10
paternally expressed 10
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PEG10 mRNA
CTD
PMID:20147733
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Pgm5
phosphoglucomutase 5
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PGM5 mRNA
CTD
PMID:22079614
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Pgr
progesterone receptor
multiple interactions decreases expression
ISO
[8-Bromo Cyclic Adenosine Monophosphate co-treated with Progesterone co-treated with Estradiol] affects the expression of and affects the phosphorylation of PGR protein 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PGR protein
CTD
PMID:23275455
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phactr3
phosphatase and actin regulator 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PHACTR3 mRNA
CTD
PMID:22079614
NCBI chr 3:165,205,247...165,423,692
Ensembl chr 3:165,205,255...165,423,153
G
Phaf1
phagosome assembly factor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PHAF1 mRNA
CTD
PMID:22079614
NCBI chr19:33,101,453...33,138,920
Ensembl chr19:33,101,490...33,138,914
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PID1 mRNA
CTD
PMID:20147733
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PIK3R3 mRNA
CTD
PMID:22079614
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Pitpnc1
phosphatidylinositol transfer protein, cytoplasmic 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PITPNC1 mRNA
CTD
PMID:20147733
NCBI chr10:92,163,558...92,428,971
Ensembl chr10:92,167,196...92,429,297
G
Pla2r1
phospholipase A2 receptor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PLA2R1 mRNA
CTD
PMID:22079614
NCBI chr 3:44,883,943...45,013,793
Ensembl chr 3:44,883,943...45,013,660
G
Plat
plasminogen activator, tissue type
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PLAT mRNA
CTD
PMID:20147733
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plcb1
phospholipase C beta 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PLCB1 mRNA
CTD
PMID:20147733
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
G
Pld1
phospholipase D1
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased activity of PLD1 protein; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]
CTD
PMID:17065600
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
G
Pmepa1
prostate transmembrane protein, androgen induced 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PMEPA1 mRNA
CTD
PMID:22079614
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pon3
paraoxonase 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PON3 mRNA
CTD
PMID:22079614
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Pou3f1
POU class 3 homeobox 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of POU3F1 mRNA
CTD
PMID:22079614
NCBI chr 5:136,910,391...136,913,371
Ensembl chr 5:136,910,391...136,913,371
G
Ppara
peroxisome proliferator activated receptor alpha
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARA mRNA
CTD
PMID:22079614
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]
CTD
PMID:15994020
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppfibp1
PPFIA binding protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PPFIBP1 mRNA
CTD
PMID:22079614
NCBI chr 4:179,807,579...179,951,428
Ensembl chr 4:179,808,794...179,951,428
G
Ppm1h
protein phosphatase, Mg2+/Mn2+ dependent, 1H
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPM1H mRNA
CTD
PMID:22079614
NCBI chr 7:58,338,661...58,599,547
Ensembl chr 7:58,338,661...58,599,547
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PPP1R3C mRNA
CTD
PMID:20147733
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
multiple interactions
ISO
[PRKACB protein mutant form results in increased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate analog] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein]
CTD
PMID:29669941
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
multiple interactions
ISO
[PRKACB protein mutant form results in increased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate analog] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein]
CTD
PMID:29669941
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRKAR2B mRNA [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of PRKAR2B protein
CTD
PMID:18467523 PMID:22079614
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
G
Prkca
protein kinase C, alpha
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRKCA mRNA
CTD
PMID:22079614
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prl
prolactin
multiple interactions increases expression decreases expression increases secretion
ISO EXP
1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Dexamethasone] results in increased expression of PRL mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein]; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]; Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]; Tobacco Smoke Pollution inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL protein 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRL mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRL protein 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of PRL protein
CTD
PMID:15774544 PMID:16709600 PMID:17065600 PMID:18815356 PMID:20147733 PMID:20955787 PMID:21273127 PMID:21467749 PMID:21903722 PMID:23275455 More...
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prmt7
protein arginine methyltransferase 7
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRMT7 mRNA
CTD
PMID:22079614
NCBI chr19:34,110,724...34,161,531
Ensembl chr19:34,110,747...34,162,577
G
Prss23
serine protease 23
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRSS23 mRNA
CTD
PMID:22079614
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Psat1
phosphoserine aminotransferase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PSAT1 mRNA
CTD
PMID:22079614
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Ptgdr2
prostaglandin D2 receptor 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PTGDR2 mRNA
CTD
PMID:22079614
NCBI chr 1:207,585,088...207,590,275
Ensembl chr 1:207,587,917...207,589,213
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTGS1 mRNA
CTD
PMID:22079614
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]; [PTGS2 co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of VEGFA
CTD
PMID:11112151 PMID:12821125
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pth
parathyroid hormone
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTH mRNA
CTD
PMID:22079614
NCBI chr 1:167,508,121...167,511,530
Ensembl chr 1:167,508,598...167,511,530
G
Pthlh
parathyroid hormone-like hormone
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTHLH mRNA
CTD
PMID:20147733
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
G
Ptk2
protein tyrosine kinase 2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [HU 211 results in increased phosphorylation of PTK2 protein]
CTD
PMID:12163181
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTP4A1 mRNA
CTD
PMID:22079614
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
G
Ptpre
protein tyrosine phosphatase, receptor type, E
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTPRE mRNA
CTD
PMID:22079614
NCBI chr 1:190,344,331...190,494,815
Ensembl chr 1:190,344,401...190,489,534
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PTPRF mRNA
CTD
PMID:22079614
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PTPRZ1 mRNA
CTD
PMID:22079614
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Pts
6-pyruvoyl-tetrahydropterin synthase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTS mRNA
CTD
PMID:22079614
NCBI chr 8:50,870,838...50,877,869
Ensembl chr 8:50,870,841...50,877,869
G
Pxylp1
2-phosphoxylose phosphatase 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PXYLP1 mRNA
CTD
PMID:22079614
NCBI chr 8:97,419,766...97,485,163
Ensembl chr 8:97,419,776...97,485,064
G
Pygl
glycogen phosphorylase L
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PYGL mRNA
CTD
PMID:22079614
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Rab25
RAB25, member RAS oncogene family
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RAB25 mRNA
CTD
PMID:22079614
NCBI chr 2:174,000,323...174,006,422
Ensembl chr 2:174,000,323...174,006,422
G
Rab27b
RAB27B, member RAS oncogene family
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RAB27B mRNA
CTD
PMID:20147733
NCBI chr18:63,597,554...63,794,124
Ensembl chr18:63,600,937...63,757,180
G
Rabgap1
RAB GTPase activating protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RABGAP1 mRNA
CTD
PMID:22079614
NCBI chr 3:21,208,012...21,326,013
Ensembl chr 3:21,208,055...21,326,013
G
Ran
RAN, member RAS oncogene family
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RAN mRNA
CTD
PMID:22079614
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rap1a
RAP1A, member of RAS oncogene family
increases activity
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased activity of RAP1A protein
CTD
PMID:10908723
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
G
Rap1b
RAP1B, member of RAS oncogene family
increases activity
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased activity of RAP1B protein
CTD
PMID:10908723
NCBI chr 7:53,423,039...53,456,349
Ensembl chr 7:53,423,130...53,456,370
G
Rarg
retinoic acid receptor, gamma
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RARG mRNA
CTD
PMID:22079614
NCBI chr 7:133,367,833...133,390,301
Ensembl chr 7:133,367,833...133,390,177
G
Rarres2
retinoic acid receptor responder 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RARRES2 mRNA
CTD
PMID:22079614
NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
G
Rasd1
ras related dexamethasone induced 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RASD1 mRNA
CTD
PMID:20147733
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rasip1
Ras interacting protein 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RASIP1 mRNA
CTD
PMID:22079614
NCBI chr 1:96,097,135...96,109,564
Ensembl chr 1:96,091,074...96,109,562
G
Rassf5
Ras association domain family member 5
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RASSF5 mRNA
CTD
PMID:22079614
NCBI chr13:42,637,513...42,703,024
Ensembl chr13:42,637,549...42,703,024
G
Rassf6
Ras association domain family member 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RASSF6 mRNA
CTD
PMID:22079614
NCBI chr14:17,433,328...17,473,565
Ensembl chr14:17,442,789...17,473,330
G
Rbms3
RNA binding motif, single stranded interacting protein 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RBMS3 mRNA
CTD
PMID:22079614
NCBI chr 8:116,305,227...117,625,730
Ensembl chr 8:116,309,882...117,625,423
G
Rbp1
retinol binding protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RBP1 mRNA
CTD
PMID:22079614
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Reps2
RALBP1 associated Eps domain containing 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of REPS2 mRNA
CTD
PMID:22079614
NCBI chr X:32,049,455...32,322,317
Ensembl chr X:32,049,399...32,317,414
G
Rfx6
regulatory factor X, 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RFX6 mRNA
CTD
PMID:22079614
NCBI chr20:31,019,784...31,073,266
Ensembl chr20:31,019,829...31,073,147
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RGS16 mRNA
CTD
PMID:22079614
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rhbg
Rh family B glycoprotein
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RHBG mRNA
CTD
PMID:22079614
NCBI chr 2:173,704,852...173,717,380
Ensembl chr 2:173,704,562...173,717,321
G
Rhob
ras homolog family member B
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RHOB mRNA
CTD
PMID:22079614
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Rhobtb1
Rho-related BTB domain containing 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RHOBTB1 mRNA
CTD
PMID:22079614
NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012
G
Rhou
ras homolog family member U
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RHOU mRNA
CTD
PMID:22079614
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
G
Rilp
Rab interacting lysosomal protein
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RILP mRNA
CTD
PMID:22079614
NCBI chr10:60,355,276...60,358,434
Ensembl chr10:60,355,278...60,358,781
G
Rin3
Ras and Rab interactor 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIN3 mRNA
CTD
PMID:22079614
NCBI chr 6:121,431,776...121,540,956
Ensembl chr 6:121,431,339...121,540,957
G
Ripk3
receptor-interacting serine-threonine kinase 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIPK3 mRNA
CTD
PMID:22079614
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
Ripor2
RHO family interacting cell polarization regulator 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIPOR2 mRNA
CTD
PMID:20147733
NCBI chr17:40,323,748...40,547,482
Ensembl chr17:40,323,867...40,548,092
G
Rnf144b
ring finger protein 144B
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RNF144B mRNA
CTD
PMID:22079614
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
G
Robo2
roundabout guidance receptor 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ROBO2 mRNA
CTD
PMID:22079614
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
G
Ror1
receptor tyrosine kinase-like orphan receptor 1
multiple interactions decreases expression
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ROR1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ROR1 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr 5:114,744,311...115,088,155
Ensembl chr 5:114,744,304...115,088,155
G
Rora
RAR-related orphan receptor A
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RORA mRNA
CTD
PMID:22079614
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rorb
RAR-related orphan receptor B
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RORB mRNA
CTD
PMID:22079614
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
G
Rph3al
rabphilin 3A-like (without C2 domains)
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RPH3AL mRNA
CTD
PMID:22079614
NCBI chr10:60,689,943...60,833,354
Ensembl chr10:60,690,031...60,801,883
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RRM2 mRNA
CTD
PMID:22079614
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rspo1
R-spondin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RSPO1 mRNA
CTD
PMID:22079614
NCBI chr 5:137,251,629...137,273,273
Ensembl chr 5:137,251,659...137,272,933
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RUNX1T1 mRNA
CTD
PMID:22079614
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
G
Rxrb
retinoid X receptor beta
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RXRB mRNA
CTD
PMID:22079614
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
G
Rxrg
retinoid X receptor gamma
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RXRG mRNA
CTD
PMID:22079614
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Ryr3
ryanodine receptor 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RYR3 mRNA
CTD
PMID:22079614
NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:99,432,505...99,704,961
G
Samd3
sterile alpha motif domain containing 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SAMD3 mRNA
CTD
PMID:22079614
NCBI chr 1:19,100,767...19,148,241
Ensembl chr 1:19,103,036...19,148,192
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SC5D mRNA
CTD
PMID:22079614
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCARB1 mRNA
CTD
PMID:22079614
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scg2
secretogranin II
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCG2 mRNA
CTD
PMID:22079614
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
G
Scgb1c1
secretoglobin, family 1C, member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCGB1C1 mRNA
CTD
PMID:22079614
NCBI chr 1:195,922,660...195,925,022
Ensembl chr 1:195,923,803...195,925,022
G
Scrg1
stimulator of chondrogenesis 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCRG1 mRNA
CTD
PMID:22079614
NCBI chr16:32,760,028...32,788,299
Ensembl chr16:32,760,028...32,788,299
G
Serpina11
serpin family A member 11
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SERPINA11 mRNA
CTD
PMID:22079614
NCBI chr 6:122,903,246...122,912,695
Ensembl chr 6:122,903,250...122,912,670
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of SERPINE1 mRNA
CTD
PMID:16997883
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpini1
serpin family I member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SERPINI1 mRNA
CTD
PMID:22079614
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sesn3
sestrin 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SESN3 mRNA
CTD
PMID:20147733
NCBI chr 8:11,133,822...11,189,436
Ensembl chr 8:11,133,678...11,185,842
G
Sf1
splicing factor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SF1 mRNA
CTD
PMID:22079614
NCBI chr 1:203,670,016...203,683,432
Ensembl chr 1:203,670,018...203,684,330
G
Sfrp1
secreted frizzled-related protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SFRP1 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
G
Sftpb
surfactant protein B
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SFTPB mRNA
CTD
PMID:16997883
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
G
Sftpc
surfactant protein C
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SFTPC mRNA
CTD
PMID:16997883
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
G
Sgcd
sarcoglycan, delta
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGCD mRNA
CTD
PMID:20147733
NCBI chr10:31,346,480...32,328,364
Ensembl chr10:31,280,511...31,724,840
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGK1 mRNA Estradiol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGK1 mRNA]; Genistein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGK1 mRNA]
CTD
PMID:21056929
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sgms1
sphingomyelin synthase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGMS1 mRNA
CTD
PMID:22079614
NCBI chr 1:229,996,673...230,259,591
Ensembl chr 1:229,998,119...230,259,603
G
Sh3bp5
SH3-domain binding protein 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SH3BP5 mRNA
CTD
PMID:22079614
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
G
Sirt1
sirtuin 1
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SIRT1 protein
CTD
PMID:16709600
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sirt3
sirtuin 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SIRT3 mRNA
CTD
PMID:23166782
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Slc16a6
solute carrier family 16, member 6
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC16A6 mRNA
CTD
PMID:20147733
NCBI chr10:94,424,377...94,447,482
Ensembl chr10:94,426,244...94,448,779
G
Slc17a5
solute carrier family 17 member 5
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC17A5 mRNA
CTD
PMID:22079614
NCBI chr 8:79,394,416...79,429,387
G
Slc25a36
solute carrier family 25 member 36
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC25A36 mRNA
CTD
PMID:16997883
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
G
Slc26a4
solute carrier family 26 member 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC26A4 protein
CTD
PMID:22811483
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
G
Slc26a7
solute carrier family 26 member 7
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC26A7 mRNA
CTD
PMID:22079614
NCBI chr 5:27,884,400...28,021,865
Ensembl chr 5:27,887,042...28,021,658
G
Slc27a2
solute carrier family 27 member 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC27A2 mRNA
CTD
PMID:22079614
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc27a4
solute carrier family 27 member 4
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC27A4 mRNA
CTD
PMID:22079614
NCBI chr 3:13,075,022...13,087,943
Ensembl chr 3:13,075,022...13,087,943
G
Slc2a12
solute carrier family 2 member 12
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC2A12 mRNA
CTD
PMID:20147733
NCBI chr 1:22,803,068...22,862,204
Ensembl chr 1:22,804,418...22,860,971
G
Slc39a8
solute carrier family 39 member 8
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC39A8 mRNA
CTD
PMID:16997883
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Slc3a2
solute carrier family 3 member 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC3A2 mRNA
CTD
PMID:22079614
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc51a
solute carrier family 51 member A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC51A mRNA
CTD
PMID:22079614
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc5a12
solute carrier family 5 member 12
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC5A12 mRNA
CTD
PMID:22079614
NCBI chr 3:97,179,326...97,228,405
Ensembl chr 3:97,179,326...97,228,405
G
Slc5a7
solute carrier family 5 member 7
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC5A7 mRNA
CTD
PMID:22079614
NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258
G
Slc6a14
solute carrier family 6 member 14
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC6A14 mRNA
CTD
PMID:16997883
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Slc6a9
solute carrier family 6 member 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC6A9 mRNA
CTD
PMID:20147733
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc7a1
solute carrier family 7 member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC7A1 mRNA
CTD
PMID:22079614
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC7A11 mRNA
CTD
PMID:22079614
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc9a1
solute carrier family 9 member A1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC9A1 mRNA
CTD
PMID:22079614
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Slco4c1
solute carrier organic anion transporter family, member 4C1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA
CTD
PMID:16997883
NCBI chr 9:97,177,497...97,229,161
Ensembl chr 9:97,178,861...97,229,715
G
Smoc1
SPARC related modular calcium binding 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SMOC1 mRNA
CTD
PMID:20147733
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
G
Smox
spermine oxidase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SMOX mRNA
CTD
PMID:20147733
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Snca
synuclein alpha
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SNCA mRNA
CTD
PMID:22079614
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Soat1
sterol O-acyltransferase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOAT1 mRNA
CTD
PMID:22079614
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOCS3 mRNA
CTD
PMID:22079614
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod1
superoxide dismutase 1
multiple interactions increases expression
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOD1 mRNA
CTD
PMID:16709600 PMID:22079614
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 protein; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA]
CTD
PMID:16709600
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox5
SRY-box transcription factor 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOX5 mRNA
CTD
PMID:22079614
NCBI chr 4:176,781,375...177,736,833
Ensembl chr 4:176,785,892...177,736,852
G
Spata9
spermatogenesis associated 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPATA9 mRNA
CTD
PMID:22079614
NCBI chr 2:5,465,573...5,504,048
Ensembl chr 2:5,465,575...5,503,538
G
Spink5
serine peptidase inhibitor, Kazal type 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPINK5 mRNA
CTD
PMID:22079614
NCBI chr18:36,264,452...36,333,143
Ensembl chr18:36,264,452...36,332,185
G
Spock2
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPOCK2 mRNA
CTD
PMID:22079614
NCBI chr20:28,037,334...28,064,272
Ensembl chr20:28,033,475...28,064,272
G
Spon1
spondin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPON1 mRNA
CTD
PMID:20147733
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spp1
secreted phosphoprotein 1
multiple interactions decreases expression
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; Dinitrochlorobenzene inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]] 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SPP1 mRNA
CTD
PMID:20453393 PMID:22079614
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRR1A mRNA
CTD
PMID:22079614
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Sprr1b
small proline-rich protein 1B
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRR1B mRNA
CTD
PMID:22079614
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
G
Sprr3
small proline-rich protein 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRR3 mRNA
CTD
PMID:22079614
NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:178,027,425...178,029,891
G
Spry2
sprouty RTK signaling antagonist 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRY2 mRNA
CTD
PMID:22079614
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Sqle
squalene epoxidase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SQLE mRNA
CTD
PMID:22079614
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Srd5a1
steroid 5 alpha-reductase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SRD5A1 mRNA
CTD
PMID:24014645
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SREBF1 mRNA
CTD
PMID:22079614
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ST3GAL1 mRNA
CTD
PMID:22079614
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ST3GAL6 mRNA
CTD
PMID:22079614
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
G
Star
steroidogenic acute regulatory protein
increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; SB 203580 inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; T-2 Toxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA] 2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [sodium arsenite results in increased expression of STAR mRNA]; 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [sodium arsenite results in increased expression of STAR protein]; Anisomycin promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Dantrolene inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Hydrocarbons, Chlorinated inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; Ryanodine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; SB 203580 promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; SB 203580 promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; sodium arsenite promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; sodium arsenite promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]]; Triiodothyronine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Valproic Acid inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Valproic Acid inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]
CTD
PMID:15713539 PMID:16254025 PMID:18815356 PMID:19849856 PMID:20732403 PMID:21726595 PMID:22079614 PMID:22546480 PMID:23183170 PMID:24014645 PMID:24328340 PMID:24740604 PMID:28859905 PMID:30951242 PMID:34896276 More...
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stard3
StAR-related lipid transfer domain containing 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STARD3 mRNA
CTD
PMID:22079614
NCBI chr10:83,357,329...83,379,873
Ensembl chr10:83,357,359...83,550,976
G
Stc1
stanniocalcin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STC1 mRNA
CTD
PMID:20147733
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STC2 mRNA
CTD
PMID:22079614
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stk17b
serine/threonine kinase 17b
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STK17B mRNA
CTD
PMID:22079614
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
G
Stra6
signaling receptor and transporter of retinol STRA6
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STRA6 mRNA
CTD
PMID:22079614
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
G
Stx2
syntaxin 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STX2 mRNA
CTD
PMID:22079614
NCBI chr12:27,678,744...27,714,751
Ensembl chr12:27,689,819...27,714,751
G
Stx3
syntaxin 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STX3 mRNA
CTD
PMID:22079614
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
G
Sult2a1
sulfotransferase family 2A member 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SULT2A1 mRNA
CTD
PMID:22079614
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
G
Sult4a1
sulfotransferase family 4A, member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SULT4A1 mRNA
CTD
PMID:22079614
NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
G
Sv2c
synaptic vesicle glycoprotein 2c
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SV2C mRNA
CTD
PMID:22079614
NCBI chr 2:27,232,933...27,428,479
Ensembl chr 2:27,232,933...27,428,477
G
Svil
supervillin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SVIL mRNA
CTD
PMID:20147733
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SYNE1 mRNA
CTD
PMID:22079614
NCBI chr 1:41,512,146...41,983,382
Ensembl chr 1:41,512,030...41,983,322
G
Syt12
synaptotagmin 12
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SYT12 mRNA
CTD
PMID:22079614
NCBI chr 1:201,729,307...201,760,192
Ensembl chr 1:201,730,371...201,759,609
G
Syt9
synaptotagmin 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SYT9 mRNA
CTD
PMID:22079614
NCBI chr 1:161,275,882...161,456,384
Ensembl chr 1:161,275,734...161,455,007
G
Tac1
tachykinin, precursor 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TAC1 mRNA
CTD
PMID:22079614
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tacc2
transforming, acidic coiled-coil containing protein 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TACC2 mRNA
CTD
PMID:22079614
NCBI chr 1:185,139,223...185,327,881
Ensembl chr 1:185,116,111...185,327,881
G
Tafa5
TAFA chemokine like family member 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TAFA5 mRNA
CTD
PMID:22079614
NCBI chr 7:118,613,731...118,835,016
Ensembl chr 7:118,613,889...118,834,353
G
Tbc1d2
TBC1 domain family, member 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TBC1D2 mRNA
CTD
PMID:20147733
NCBI chr 5:60,884,114...60,931,717
Ensembl chr 5:60,884,124...60,931,352
G
Tcf21
transcription factor 21
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TCF21 mRNA
CTD
PMID:20147733
NCBI chr 1:22,701,353...22,704,212
Ensembl chr 1:22,701,353...22,704,202
G
Tef
TEF transcription factor, PAR bZIP family member
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TEF mRNA
CTD
PMID:22079614
NCBI chr 7:113,317,191...113,341,783
Ensembl chr 7:113,317,283...113,341,783
G
Tent5a
terminal nucleotidyltransferase 5A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TENT5A mRNA
CTD
PMID:22079614
NCBI chr 8:86,222,294...86,229,045
Ensembl chr 8:86,225,357...86,229,045
G
Tesk1
testis associated actin remodelling kinase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TESK1 mRNA
CTD
PMID:22079614
NCBI chr 5:57,691,922...57,697,698
Ensembl chr 5:57,691,969...57,697,698
G
Testin
testin gene
decreases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TESTIN mRNA lonidamine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TESTIN mRNA]
CTD
PMID:11090432
NCBI chr17:3,824,222...3,859,385
Ensembl chr17:3,846,899...3,859,385
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TFPI2 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB1 mRNA
CTD
PMID:16997883
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TGFB1I1 mRNA
CTD
PMID:22079614
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tgfb2
transforming growth factor, beta 2
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB2 mRNA
CTD
PMID:16997883
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Tgfb3
transforming growth factor, beta 3
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB3 mRNA
CTD
PMID:16997883
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tgfbr2
transforming growth factor, beta receptor 2
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TGFBR2 mRNA
CTD
PMID:22079614
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]]
CTD
PMID:21726595
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TIPARP mRNA
CTD
PMID:22079614
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tlcd3a
TLC domain containing 3A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TLCD3A mRNA
CTD
PMID:22079614
NCBI chr10:61,057,470...61,065,293
Ensembl chr10:61,058,042...61,065,283
G
Tmc5
transmembrane channel-like 5
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TMC5 mRNA
CTD
PMID:16997883
NCBI chr 1:172,914,915...172,999,478
Ensembl chr 1:172,914,457...172,999,474
G
Tmod1
tropomodulin 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TMOD1 mRNA
CTD
PMID:20147733
NCBI chr 5:60,316,445...60,393,957
Ensembl chr 5:60,338,512...60,393,956
G
Tmx4
thioredoxin-related transmembrane protein 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TMX4 mRNA
CTD
PMID:20147733
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnc
tenascin C
multiple interactions increases expression
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNC mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNC mRNA
CTD
PMID:16997883 PMID:20147733
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]] 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]
CTD
PMID:10495789 PMID:11230753 PMID:21803157
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFAIP3 mRNA [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFAIP3 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFRSF10A mRNA
CTD
PMID:22079614
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFRSF12A mRNA
CTD
PMID:22079614
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf19
TNF receptor superfamily member 19
decreases expression increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TNFRSF19 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFRSF19 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfsf4
TNF superfamily member 4
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFSF4 mRNA
CTD
PMID:16997883
NCBI chr13:73,723,329...73,746,809
Ensembl chr13:73,723,329...73,746,788
G
Tnnt2
troponin T2, cardiac type
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNNT2 mRNA
CTD
PMID:22079614
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tp53
tumor protein p53
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53 protein
CTD
PMID:10642304 PMID:11802967
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tph2
tryptophan hydroxylase 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TPH2 mRNA
CTD
PMID:22079614
NCBI chr 7:50,685,694...50,789,424
Ensembl chr 7:50,685,694...50,789,424
G
Tpm1
tropomyosin 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TPM1 mRNA
CTD
PMID:16997883
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
G
Tpmt
thiopurine S-methyltransferase
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TPMT mRNA
CTD
PMID:22079614
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRIB3 mRNA
CTD
PMID:22079614
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim2
tripartite motif-containing 2
multiple interactions increases expression
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TRIM2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRIM2 mRNA
CTD
PMID:16997883 PMID:20147733
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim24
tripartite motif-containing 24
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRIM24 mRNA
CTD
PMID:22079614
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
G
Trip10
thyroid hormone receptor interactor 10
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TRIP10 mRNA
CTD
PMID:22079614
NCBI chr 9:2,133,085...2,147,795
Ensembl chr 9:2,133,671...2,147,799
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRPA1 mRNA
CTD
PMID:22079614
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Tshz2
teashirt zinc finger homeobox 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TSHZ2 mRNA
CTD
PMID:20147733
NCBI chr 3:158,405,469...158,666,915
Ensembl chr 3:158,405,423...158,850,128
G
Ttc9
tetratricopeptide repeat domain 9
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TTC9 mRNA
CTD
PMID:22079614
NCBI chr 6:101,333,274...101,368,110
Ensembl chr 6:101,333,141...101,368,110
G
Txn1
thioredoxin 1
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in decreased expression of TXN1 protein]
CTD
PMID:20453393
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UGT2B17 mRNA
CTD
PMID:22079614
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UGT2B7 mRNA
CTD
PMID:22079614
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Unc5b
unc-5 netrin receptor B
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UNC5B mRNA
CTD
PMID:22079614
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Ushbp1
USH1 protein network component harmonin binding protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of USHBP1 mRNA
CTD
PMID:22079614
NCBI chr16:18,057,321...18,067,933
Ensembl chr16:18,057,326...18,067,877
G
Uts2
urotensin 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UTS2 mRNA
CTD
PMID:22079614
NCBI chr 5:161,450,846...161,456,235
Ensembl chr 5:161,450,846...161,456,237
G
Uty
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UTY mRNA
CTD
PMID:22079614
NCBI chr Y:942,838...1,105,313
Ensembl chr Y:924,168...1,103,422
G
Vdr
vitamin D receptor
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VDR mRNA
CTD
PMID:22079614
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
multiple interactions increases expression
ISO
[PTGS2 co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of VEGFA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VEGFA mRNA
CTD
PMID:10788502 PMID:12821125 PMID:20147733
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VEGFC mRNA
CTD
PMID:22079614
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vgf
VGF nerve growth factor inducible
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VGF mRNA
CTD
PMID:22079614
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
G
Vgll3
vestigial-like family member 3
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VGLL3 mRNA
CTD
PMID:20147733
NCBI chr11:3,642,993...3,692,590
Ensembl chr11:3,643,069...3,689,140
G
Vipr1
vasoactive intestinal peptide receptor 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VIPR1 mRNA
CTD
PMID:22079614
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
G
Vldlr
very low density lipoprotein receptor
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VLDLR mRNA
CTD
PMID:22079614
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vmo1
vitelline membrane outer layer 1 homolog
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VMO1 mRNA
CTD
PMID:20147733
NCBI chr10:55,227,944...55,234,794
Ensembl chr10:55,227,944...55,229,289
G
Wdr17
WD repeat domain 17
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of WDR17 mRNA
CTD
PMID:22079614
NCBI chr16:37,059,923...37,191,125
Ensembl chr16:37,059,895...37,191,122
G
Whrn
whirlin
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of WHRN mRNA
CTD
PMID:22079614
NCBI chr 5:76,828,308...76,911,945
Ensembl chr 5:76,828,301...76,912,223
G
Wif1
Wnt inhibitory factor 1
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of WIF1 mRNA
CTD
PMID:16997883
NCBI chr 7:56,548,060...56,618,364
Ensembl chr 7:56,548,053...56,618,360
G
Wnt4
Wnt family member 4
decreases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of WNT4 mRNA [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA; NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA]
CTD
PMID:22079614 PMID:23275455
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Wnt5b
Wnt family member 5B
multiple interactions
ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT5B mRNA
CTD
PMID:16997883
NCBI chr 4:152,609,566...152,733,790
Ensembl chr 4:152,609,569...152,733,407
G
Xbp1
X-box binding protein 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of XBP1 mRNA
CTD
PMID:22079614
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Zbtb12
zinc finger and BTB domain containing 12
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZBTB12 mRNA
CTD
PMID:22079614
NCBI chr20:3,937,668...3,940,514
G
Zbtb18
zinc finger and BTB domain containing 18
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZBTB18 mRNA
CTD
PMID:22079614
NCBI chr13:89,439,501...89,447,958
Ensembl chr13:89,439,420...89,448,862
G
Zbtb32
zinc finger and BTB domain containing 32
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZBTB32 mRNA
CTD
PMID:22079614
NCBI chr 1:85,841,931...85,851,116
Ensembl chr 1:85,841,931...85,844,236
G
Zfp36l1
zinc finger protein 36, C3H type-like 1
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZFP36L1 mRNA
CTD
PMID:22079614
NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:98,930,718...98,935,748
G
Zfp36l2
zinc finger protein 36, C3H type-like 2
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZFP36L2 mRNA
CTD
PMID:22079614
NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
G
Zfp46
zinc finger protein 46
decreases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZNF436 mRNA
CTD
PMID:22079614
NCBI chr 5:148,519,398...148,529,903
Ensembl chr 5:148,520,855...148,529,459
G
Znf454
zinc finger protein 454
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZNF454 mRNA
CTD
PMID:22079614
NCBI chr10:35,183,729...35,200,450
Ensembl chr10:35,185,028...35,245,505
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all